
Plant I was established in 1984, and is dedicated to the production of finished dosage forms of penicillin-like beta-lactams. The plant has four floors, each encompassing a base area of 1600 square meters.
The following pharmaceutical activities are licensed by the Turkish Health Authorities for the Plant I - Penicillin-like Beta-lactam Products.
| Annual Capacity* | |||||||||||||||||||
| Sterile powder for injection | 30 million vials (10 ml) | ||||||||||||||||||
| Tablets | 83 million tablets | ||||||||||||||||||
| Film-coated tablets (coating capacity) | 45 tons | ||||||||||||||||||
| Hard gelatine capsules | 54 million capsules | ||||||||||||||||||
| Dry powder suspension | 2,6 million bottles (100 ml pp) | ||||||||||||||||||
Plant II was established in 1996, and is dedicated to the production of finished dosage forms of cephalosporin-like beta-lactams. The plant has four floors, each encompassing a base area of 1050 square meters.
The following pharmaceutical activities are licensed by Turkish Health Authorities for the Plant II - Cephalosporin-like Beta-lactam Products.
| Annual Capacity* | |||||||||||||||||||
| Sterile powder for injection | 16 million vials (10 ml) | ||||||||||||||||||
| Tablets | 96 million tablets | ||||||||||||||||||
| Film-coated tablets (coating capacity) | 45 tons | ||||||||||||||||||
| Hard gelatine capsules | 42 million capsules | ||||||||||||||||||
| Dry powder suspension | 1,2 million bottles (100 ml pp) | ||||||||||||||||||